Novavax COVID-19 vaccine 90.4% effective in clinical trial, company says
Novavax announced on Monday that its COVID-19 vaccine was found to be over 90% effective overall, and offered 100% protection against...
Full Article
Novavax COVID-19 vaccine 90.4% effective in clinical trial, company says
Upworthy
0 shares
1 views
You might like
Related news coverage
Q BioMed has a winner in cancer bone pain drug Strontium89 and a deep pipeline of biomedical assets
Proactive Investors
Acquires undervalued biomedical assets to accelerate their development Developing drugs and therapies to treat pediatric nonverbal..
-
NA Proactive news snapshot: Alternus Energy, Bioasis Technologies, Highgold Mining, Western Magnesium, Mindset Pharma UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Plurilock Security, American Eagle Gold, Playgon Games, Kenorland Minerals, TRACON Pharmaceuticals UPDATE …
Proactive Investors
-
When can your kid return to school? AIIMS chief answers
MENAFN.com
-
NA Proactive news snapshot: Power REIT, Byrna Technologies, CytoDyn, Progressive Planet Solutions, AIM ImmunoTech UPDATE …
Proactive Investors
Advertisement
More coverage
CureVac collapses 45% after disappointing results from COVID-19 vaccine trial
Invezz
CureVac NV (NASDAQ: CVAC) slipped about 45% in the stock market on Thursday morning as the company said the late-stage trial showed..
-
NA Proactive news snapshot: CytoDyn, Progressive Planet Solutions, AIM ImmunoTech, Arizona Silver Exploration UPDATE …
Proactive Investors
-
Qatar to provide one million COVID-19 vaccine for fans attending 2022 FIFA World Cup
MENAFN.com
-
Wall Street ends mixed after jobless data surprise
Proactive Investors
-
Wall Street stumbles into midday despite jobless data surprise
Proactive Investors